1. Home
  2. FKWL vs CLRB Comparison

FKWL vs CLRB Comparison

Compare FKWL & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Wireless Corp.

FKWL

Franklin Wireless Corp.

SELL

Current Price

$2.19

Market Cap

26.0M

Sector

Utilities

ML Signal

SELL

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$1.16

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FKWL
CLRB
Founded
1981
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
24.5M
IPO Year
1997
2008

Fundamental Metrics

Financial Performance
Metric
FKWL
CLRB
Price
$2.19
$1.16
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $11.50
AVG Volume (30 Days)
7.9K
★ 159.7K
Earning Date
11-17-2026
11-10-2026
Dividend Yield
★ 1.79%
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $36,514,405.00
N/A
Revenue This Year
$32.55
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.12
$1.12
52 Week High
$5.19
$4.70

Technical Indicators

Market Signals
Indicator
FKWL
CLRB
Relative Strength Index (RSI) 34.36 35.29
Support Level N/A N/A
Resistance Level $2.48 $3.40
Average True Range (ATR) 0.05 0.09
MACD -0.00 0.04
Stochastic Oscillator 0.00 44.00

Price Performance

Historical Comparison
FKWL
CLRB

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics. Geographically, it derives revenue from North America, which derives maximum revenue; and Asia.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: